Biosensor assay of neuropathy target esterase in whole blood as a new approach to OPIDN risk assessment: review of progress

Abstract

Organophosphates (OPs) that inhibit neuropathy target esterase (NTE) with subsequent ageing can produce OP-induced delayed neuropathy (OPIDN). NTE inhibition in lymphocytes can be used as a biomarker of exposure to neuropathic OPs. An electrochemical method was developed to assay NTE in whole blood. The high sensitivity of the tyrosinase carbon-paste biosensors for the phenol produced by hydrolysis of the substrate, phenyl valerate, allowed NTE activity to be measured in diluted samples of whole blood, which cannot be done using the standard colorimetric assay. The biosensor was used to establish correlations of NTE inhibitions in blood with that in lymphocytes and brain after dosing hens with a neuropathic OP. The results of further studies demonstrated that whole blood NTE is a reliable biomarker of neuropathic OPs for up to 96 hours after exposure. These validation results suggest that the biosensor NTE assay for whole blood could be developed to measure human exposure to neuropathic OPs as a predictor of OPIDN. The small blood volume required (100 μL), simplicity of sample preparation and rapid analysis times indicate that the biosensor should be useful in biomonitoring and epidemiological studies. The present paper is an overview of our previous and ongoing work in this area. Human & Experimental Toxicology (2007) 26, 273-282

Keywords

OPIDN neuropathy target esterase (NTE)biomarker blood organophosphates (OPs)tyrosinase biosensors

References

Davis CS , Richardson RJ Organophosphorus compounds. In Spencer PS , Schaumburg HH eds. Experimental and clinical neurotoxicology. Williams & Wilkins, 1980: 527-544.

Richardson RJ Organophosphate poisoning, delayed neurotoxicity. In Wexler P ed. Encyclopedia of toxicology, second edition, Volume 3 (4 vols). Elsevier, Ltd., 2005: 302-306.

Johnson MK The target for initiation of delayed neurotoxicity by organophosphorus esters: biochemical studies and toxicological applications. In Hodgson E , Bend JR , Philpot RM eds. Reviews in biochemical toxicology , Volume 4. Elsevier, 1982: 141-212.

Makhaeva GF , Malygin VV , Martynov IV Organophosphorus pesticide induced delayed neurotoxicity (Review) . Agrochemistry (Russian) 1987; 12: 103-124.

Abou-Donia MB Organophosphorus ester-induced delayed neurotoxicity . Annu Rev Pharmacol Toxicol 1981; 21: 511-48.

Cole DC , Carpio F. , Julian J. , Léon N. Assessment of peripheral nerve function in an Ecuadorian rural population exposed to pesticides. J Toxicol Environ Health A 1998; 55: 77-91.

Lotti M. Organophosphate-induced delayed polyneuropathy in humans: perspectives for biomonitoring. Trends Pharmacol Sci 1987 ; 81: 176-77.

Glynn P. Neuropathy target esterase. Biochem J 1999 ; 344: 625-31.

Huggins DJ , Richardson RJ Brainstem axolemmal protein phosphorylation in vitro in hens dosed with di-1-butyl-2,2-dichlorovinyl phosphate. J Toxicol Environ Health A 1999; 56: 263- 82.

10.

Johnson MK

Organophosphates and delayed neuropathy - is NTE alive and well?

Toxicol Appl Pharmacol 1990; 102: 385-99.

11.

Randall JC , Yano BL , Richardson RJ Potentiation of organophosphorus compound-induced delayed neurotoxicity (OPIDN) in the central and peripheral nervous system of the adult hen: distribution of axonal lesions. J Toxicol Environ Health 1997; 51: 571-90.

12.

Richardson RJ Interactions of organophosphorus compounds with neurotoxic esterase. In Chambers JE , Levi PE eds. Organophosphates: chemistry, fate, and effects. Academic Press, 1992 : 299-323.

13.

Richardson RJ Assessment of the neurotoxic potential of chlorpyrifos relative to other organophosphorus compounds: a critical review of the literature. J Toxicol Environ Health 1995; 44: 135-65.

14.

Barber D. , Correll L. , Ehrich M. Comparative effectiveness of organophosphorus protoxicant activating systems in neuroblastoma cells and brain homogenates. J Toxicol Environ Health A 1999; 57: 63-74.

15.

Weiner ML , Jortner BS Organophosphate-induced delayed neurotoxicity of triarylphosphates . Neurotoxicology 1999; 20: 653-73.

16.

Moretto A. Experimental and clinical toxicology of anticholinesterase agents . Toxicol Lett 1998; 102/103: 509-13.

17.

Costa LG Biomarker research in neurotoxicology: the role of mechanistic studies to bridge the gap between laboratory and epidemiological investigations. Environ Health Perspect 1996; 104 Suppl. 1: 55-67.

18.

Bertoncin D. , Russolo A. , Caroldi S. , Lotti M. Neuropathy target esterase in human lymphocytes . Arch Environ Health 1985; 40: 221-30.

19.

Dudek BR , Richardson RJ Evidence for the existence of neurotoxic esterase in neuronal and lymphatic tissue of the adult hen. Biochem Pharmacol 1982; 31: 1117-21.

20.

Maroni M. , Bleecker ML Neuropathy target esterase in human lymphocytes and platelets. J Appl Toxicol 1986; 6: 1-7.

21.

Richardson RJ , Dudek BR Neurotoxic esterase: characterization and potential for a predictive screen for exposure to neuropathic organophosphates . In Miyamoto J , Kearney PC eds. Pesticide chemistry: human welfare and the environment, Volume 3. Pergamon , 1983: 491-95.

22.

Lotti M. Biological monitoring for organophosphate-induced delayed polyneuropathy . Toxicol Lett 1986; 33: 167-72.

23.

Lotti M. , Becker CE , Aminoff MJ , Woodrow JE , Seiber JN , Talcott RE , Richardson RJ Occupational exposure to the cotton defoliants DEF and merphos. A rational approach to monitoring organophosphorus-induced neurotoxicity. J Occup Med 1983; 25: 517-22.

24.

Lotti M. , Moretto A. , Zoppellari R. , Dainese R. , Rizzuto N. , Barusco G. Inhibition of lymphocytic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneuropathy. Arch Toxicol 1986; 59: 176-79.

25.

Schwab BW , Richardson RJ Lymphocyte and brain neurotoxic esterase: dose and time dependence of inhibition in the hen examined with three organophosphorus esters. Toxicol Appl Pharmacol 1986; 83: 1-9.

26.

Ehrich M. Neurotoxic esterase inhibition: predictor of potential for organophosphate-induced delayed neuropathy. In Blancato JN, Brown RN, Dary CC, Saleh MA eds. Biomarkers for agrochemicals and toxic substances. ACS Symposium Series 643 . American Chemical Society, 1996: 79-93.

27.

Mutch E. , Blain PG , Williams FM Interindividual variations in enzymes controlling organophosphate toxicity in man. Hum Exp Toxicol 1992; 11: 109-16.

28.

Wilson BW , Henderson JD Blood esterase determinations as markers of exposure. Rev Environ Contam Toxicol 1992; 128: 55-69.

29.

Sigolaeva LV , Makower A. , Eremenko AV , Makhaeva GF , Malygin VV , Kurochkin IN , Scheller F. Bioelectrochemical analysis of neuropathy target esterase activity in blood. Anal Biochem 2001; 290: 1-9.

30.

Johnson MK Improved assay of neurotoxic esterase for screening organophosphates for delayed neurotoxicity potential. Arch Toxicol 1977 ; 67: 113-15.

31.

Kayyali US , Moore TB , Randall JC , Richardson RJ Neurotoxic esterase (NTE) assay: optimized conditions based on detergent-induced shifts in the phenol/ 4-aminoantipyrine chromophore spectrum. J Anal Toxicol 1991; 15: 86-89.

32.

Burton SG

Biocatalysis with polyphenol oxidase: a review. Catal

Today 1994; 22: 459-87.

33.

Uchiyama S. , Hasebe Y. , Shimizu H. , Ishihara H. Enzyme-based catechol sensor based on the cyclic reaction between catechol and 1,2-benzoquinone, using L-ascorbate and tyrosinase. Anal Chim Acta 1993; 276: 341-45.

34.

Makower A. , Eremenko AV , Streffer K. , Wollenberger U. , Scheller FW Tyrosinase-glucose dehydrogenase substrate recycling biosensor. Highly sensitive measurement of phenolic compounds. J Chem Technol Biotechnol 1996; 65: 39-44.

35.

Skladal P.

Mushroom tyrosinase-modified carbon paste electrode as an amperometric biosensor for phenols. Coll Czech

Chem Commun 1991; 56: 1427-33.

36.

Wang J. , Lopez D. Amperometric biosensor for phenols based on a tyrosinase-graphite-epoxy biocomposite . Analyst 1994; 119: 455-58.

37.

Marko-Varga G. , Emneus J. , Gorton L. , Ruzgas T.

Development of enzyme-based amperometric sensors for the determination of phenolic compounds. Trends

Anal Biochem 1995; 14: 319-20.

38.

Sigolaeva LV , Eremenko AV , Makower A. , Makhaeva GF , Malygin VV , Kurochkin IN A new approach for determination of neuropathy target esterase activity. Chem Biol Interact 1999; 119/120: 559-65.

39.

Sokolovskaya LG , Sigolaeva LV , Eremenko AV , Gachok IV , Makhaeva GF , Strakhova NN , Malygin VV , Richardson RJ , Kurochkin IN Improved electrochemical analysis of neuropathy target esterase activity by a tyrosinase carbon paste electrode modified by 1-methoxyphenazine methosulfate. Biotechnol Lett 2005; 27: 1211-18.

40.

Richardson RJ , Davis CS , Johnson MK Subcellular distribution of marker enzymes and of neurotoxic esterase in adult hen brain. J Neurochem 1979; 32: 607-15.

41.

Makhaeva GF , Malygin VV A stable preparation of hen brain neuropathy target esterase for rapid biochemical assessment of neurotoxic potential of organophosphates. Chem Biol Interact 1999; 119/120: 551-57.

42.

Makhaeva GF , Filonenko IV , Yankovskaya VL , Fomicheva SB , Malygin VV Comparative studies of O,O-dialkyl-O-chloromethylchloroformimino phosphates interaction with neuropathy target esterase and acetylcholinesterase . Neurotoxicology 1998; 19: 623-28.

43.

Nielsen H. Quantitative micro determination of proteins and peptides. Acta Chem Scand 1958; 12: 38-43.

44.

Makhaeva GF , Sigolaeva LV , Zhuravleva LV , Eremenko AV , Kurochkin IN , Malygin VV, Richardson RJ. Biosensor detection of neuropathy target esterase in whole blood as a biomarker of exposure to neuropathic organophosphorus compounds . J Toxicol Environ Health A 2003; 66: 599-610.

45.

International recommendations (Ethical codex) for carrying out the experiments on animals and corresponding guidelines approved by the USSR and Rusian Federation authorities (Ministry of Education order #742) 2001. Retrieved from http://www.bio.msu.ru/etica.html .

46.

Padilla S. , Veronesi B. The relationships between neurological damage and neurotoxic esterase inhibition in rats acutely exposed to tri-ortho-cresyl phosphate. Toxicol Appl Pharmacol 1985; 78: 78-87.

47.

Makhaeva GF , Sigolaeva LV , Zhuravleva LV , Eremenko AV , Kurochkin IN , Richardson RJ , Malygin VV Neuropathy target esterase in whole blood: biomarker for exposure to neuropathic organophosphorus compounds. ASA Newsl 2002 ; 02/05: 16-21.

48.

Lotti M. , Johnson MK Neurotoxicity of organophosphorus pesticides: Predictions can be based on in vitro studies with hen and human enzymes. Arch Toxicol 1978; 41: 215-21.

49.

Davis CS , Richardson RJ Neurotoxic esterase: characterization of the solubilized enzyme and the conditions for its solubilization from chicken brain microsomal membranes with ionic, zwitterionic, or nonionic detergents. Biochem Pharmacol 1987; 36: 1393-99.

50.

Novak R. , Padilla S. An in vitro comparison of rat and chicken brain neurotoxic esterase . Fundam Appl Toxicol 1986; 6: 464-71.

51.

Yoshida M. , Wu SY , Casida JE Reactivity and stereospecificity of neuropathy target esterase and alpha-chymotrypsin with 2-substituted-4H-1,3,2-benzodioxaphosphorin 2-oxides . Toxicol Lett 1994; 74: 167-76.

52.

Sigolaeva LV , Makower A. , Eremenko AV , Makhaeva GF , Malygin VV , Kurochkin IV , Scheller F. Neuropathy target esterase activity in blood: biosensor analysis. Neurotoxicology 2000; 21: 637-38.